The LOAd family includes a range of novel tumor microenvironment (TME) gene engineering vectors with different immunostimulatory genes that are currently being evaluated for mechanisms-of-action (MOA) and proof-of-concept (POC).
See our pipeline
If you live in the US and have pancreatic cancer or melanoma, you may be eligible for inclusion in our clinical trials LOKON001 or LOKON003. If you live in Sweden and have pancreatic cancer, melanoma, or ovarian cancer, you may be eligible for inclusion in our clinical trials LOKON002 or LOKON003. If you are interested to participate as a study patient in our trials, please, discuss with your treating physician.
Read more
Lokon Pharma is a Swedish biotech company in the forefront of developing tumor microenvironment (TME) gene engineering vectors for cancer. Innovative gene engineering, solid expertise in cancer biology and immunology, as well as a genuine curiosity in life science expand Lokon’s pipeline towards groundbreaking new therapeutics for patients with high unmet medical need.
Read more
We have been informed that individuals are receiving fraudulent job interview invitations claiming to be from Lokon Pharma. Please be aware that Lokon Pharma is not conducting any recruitment or job interviews at this time.
Any message, email, or phone call offering an interview or job opportunity with our company is not legitimate.
If you receive such communication, do not respond, do not provide any personal information, and do not send any money.
These contacts are part of an ongoing scam.
For your safety, please report suspicious messages to your local authorities